Sakar Healthcare (NSE:SAKAR) Accounts Payable & Accrued Expense : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Sakar Healthcare Accounts Payable & Accrued Expense?

Sakar Healthcare's quarterly accounts payable & accrued expense increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹179 Mil) but then declined from Sep. 2023 (₹179 Mil) to Dec. 2023 (₹0 Mil).

Sakar Healthcare's annual accounts payable & accrued expense increased from Mar. 2021 (₹198 Mil) to Mar. 2022 (₹305 Mil) but then declined from Mar. 2022 (₹305 Mil) to Mar. 2023 (₹261 Mil).

Sakar Healthcare Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sakar Healthcare's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sakar Healthcare Accounts Payable & Accrued Expense Chart

Sakar Healthcare Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

60.30

54.41

197.80

305.04

260.88

Sakar Healthcare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	260.88	-	178.76	-

Sakar Healthcare Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sakar Healthcare (NSE:SAKAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sakar Healthcare Ltd (NSE:SAKAR) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

406, Silver Oaks Comm. Complex, Opposite Arun Society, Paldi, Ahmedabad, GJ, IND, 382 007

Website

https://www.sakarhealthcare.com

Sakar Healthcare Ltd is engaged in manufacturing Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. The company offers its products to Sri Lanka, the Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, Costa Rica, Panama, El Salvador, and Paraguay.

Sakar Healthcare (NSE:SAKAR) Headlines

No Headlines